×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
GSK buys US-based cancer specialist Sierra Oncology for $1.9 billion
Yahoo News UK
Pharmaceutical giant GlaxoSmithKline (GSK) has bought California-based cancer treatment company Sierra Oncology for $1.9 billion (£1.5...
1 week ago
In pleasant surprise for GSK, FDA approves Jakafi challenger Ojjaara in broad blood cancer use
Fierce Pharma
For the JAK inhibitor momelotinib, which GSK obtained in its $1.9 billion acquisition of Sierra Oncology, a three-month delay at the FDA was...
8 months ago
GSK acquires US-based Sierra Oncology for $1.9bn
Pharmaceutical Technology
GlaxoSmithKline (GSK) has completed the acquisition of all outstanding shares of Sierra Oncology in a deal totalling $1.9bn (£1.6bn),...
22 months ago
FDA Approves GSK's New Blood Cancer Treatment
Bloomberg
The US Food and Drug Administration cleared a new treatment from GlaxoSmithKline Plc for a rare blood cancer, bolstering the UK...
8 months ago
Stephen Dilly Receives the 2023 Bloom Burton Award
BioSpace
Published: Sep 29, 2023. Toronto, Ontario--(Newsfile Corp. - September 29, 2023) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Stephen Dilly,...
7 months ago
Sierra Oncology and GlaxoSmithKline Acquisition Backstory
Fierce Biotech
Sierra Oncology was ready to take momelotinib to the market, but it needed help. What started out as an effort to find a strategic partner...
24 months ago
Wilson Sonsini Advises Sierra Oncology on $1.9 Billion Acquisition by GSK
Wilson Sonsini
On April 13, 2022, GlaxoSmithKline plc (GSK) and Sierra Oncology, Inc. announced that they have entered into an agreement under which GSK...
25 months ago
GSK to buy Sierra Oncology amid pressure to boost drug pipeline
Reuters
Britain's GlaxoSmithKline sought to bolster its cancer business on Wednesday by agreeing a $1.9 billion deal to buy U.S. drug developer...
25 months ago
GlaxoSmithKline to buy Sierra Oncology for £1.5bn to boost cancer drug pipeline
Financial Times
Sierra's bone marrow cancer treatment had positive clinical trial results in January.
25 months ago
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
Business Wire
GlaxoSmithKline plc (LSE/NYSE: GSK) and Sierra Oncology, Inc (Nasdaq: SRRA) today announced that the companies have entered into an...
25 months ago